TNF and inflammatory bowel disease: Data consistent with this study show that a biologic agent, an inhibitor of tumor necrosis factor (TNF)-α, effectively accelerated the rate of mucosal healing in patients with IBD, signaling great progress in the treatment of IBD [19].